 |
 |
 |
Search Stock:
Jagsonpal Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Jagsonpal Pharmaceuticals (JAGSNPHARM) Key Ratios
P/E
Company33.32
Sector7.51
A Price-to-Earnings of 33.32 means investors pay 33.32 units per 1 unit of earnings. This is higher than the sector average of 7.51.
P/B
Company5.49
Sector4.33
A P/B ratio of 5.49 shows market value relative to book value. This is higher than the sector average of 4.33.
ROA
Company14.36%
Sector-17.9%
Return on Assets shows a 14.36% profit per unit of asset. This is lower than the sector average of -17.9%.
ROE
Company15.6%
Sector-3.17%
Return on Equity creates 15.6% profit per unit of equity. This is higher than the sector average of -3.17%.
ROCE
Company20.59%
Sector6.29%
ROCE indicates 20.59% operating earnings per unit of capital. This is higher than the sector average of 6.29%.
EV/EBITDA
Company20.05
Sector14.44
EV/EBITDA of 20.05 means value is 20.05 times core earnings. This is higher than the sector average of 14.44.
Jagsonpal Pharmaceuticals Share Price Analysis Local DB
Jagsonpal Pharmaceuticals share price is ₹237.03, day high (share price) is ₹239.55, day low (share price) is ₹235.50 and volume is 58,876. 52 Week high share price for Jagsonpal Pharmaceuticals is ₹264.50 on 30 Jun 2026 and 52 week low share price for Jagsonpal Pharmaceuticals is ₹155.00 on 22 Jan 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Jagsonpal Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 53.5, 50 DMA (50 Displaced Moving Average) is 231.92 and 200 DMA (200 Displaced Moving Average) is 202.78.
▼
₹237.03
-2.60 (-1.09%)
As of 02 Sep, 2026
Open
₹239.49
Day High - Low
₹239.55 - ₹235.50
Volume
58,876
52 Weeks High
₹264.50
on 30 Jun 2026
52 Weeks Low
₹155.00
on 22 Jan 2026
RSI (14)
53.5
50 DMA
231.92
200 DMA
202.78
Loading...
Jagsonpal Pharmaceuticals (JAGSNPHARM) Technical Analysis
₹237.03
-2.60
02 Sep, 2026
Jagsonpal Pharmaceuticals Technical Data and Analysis available in multiple timeframes.
Jagsonpal Pharmaceuticals Oscillators Analysis
On the Day timeframe, the outlook for JAGSNPHARM is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 53.5.
Jagsonpal Pharmaceuticals Price Action
Jagsonpal Pharmaceuticals Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 53.47 |
| Stoch %K (14, 3, 3) | 63.65 |
| CCI (20) | 29.74 |
| ADX (14) | 36.16 |
| Awesome Osc | 6.99 |
| Momentum (10) | 6.75 |
| MACD (12, 26, 9) | 2.87 |
| MACD Signal | 2.77 |
| Stoch RSI (14) | 62.48 |
| Williams %R (14) | -46.94 |
| Bull/Bear Power | 0.68 |
| Ultimate Osc | 40.73 |
| MFI (14) | 78.35 |
| ROC (21) | 0.22 |
| ROC (125) | 40.53 |
| ATR (14) | 8.37 |
Jagsonpal Pharmaceuticals Moving Averages
JAGSNPHARM is trading above 9 out of 14 SMAs.
237.03
CURRENT PRICE
Bullish Moving Averages
9
Bearish Moving Averages
5
5 SMA238.71
8 SMA239.74
9 SMA239.39
10 SMA238.75
12 SMA237.39
20 SMA234.87
21 SMA235.10
26 SMA234.86
30 SMA233.31
34 SMA232.02
50 SMA231.92
100 SMA218.79
150 SMA204.92
200 SMA202.78
| Ichimoku Base | 243.35 | Below Base |
| VWMA (20) | 235.46 | Above VWMA |
| HMA (9) | 239.02 | Below HMA |
Jagsonpal Pharmaceuticals Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
- RSI at 53.47 reflects mild positive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Jagsonpal Pharmaceuticals Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 250.64 | 250.10 | 241.57 | 247.51 |
| Resistance 2 | 247.51 | 247.24 | 240.93 | 244.81 |
| Resistance 1 | 243.57 | 243.03 | 240.28 | 243.14 |
| Pivot Point | 240.44 | 240.17 | 239.63 | 240.44 |
| Support 1 | 236.50 | 235.96 | 238.98 | 237.74 |
| Support 2 | 233.37 | 233.10 | 238.33 | 236.07 |
| Support 3 | 229.43 | 228.89 | 237.69 | 233.37 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Jagsonpal Pharmaceuticals - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 69.05% | 67.89% | 67.39% | 67.54% |
| FII | 2.30% | 2.44% | 2.12% | 2.12% |
| DII (Other) | 0.62% | 0.22% | 0.15% | 0.09% |
| Retail & Others | 28.03% | 29.45% | 30.34% | 30.25% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Jagsonpal Pharmaceuticals - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|
Jagsonpal Pharmaceuticals - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 12 Sep 2025 | ₹2.5 | View Details |
|
Announcement date
06 May 2025
Ex dividend date
12 Sep 2025
Record date
12 Sep 2025
Dividend type
Final
Amount
2.5
Dividend %
125.0
Details
Rs.2.5000 per share(125%)Final Dividend
|
|||
Jagsonpal Pharmaceuticals Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...